{"id":"https://openalex.org/W1419085830","doi":"https://doi.org/10.1158/1538-7445.am2015-4133","title":"Abstract 4133: ODM-203, a novel, selective and balanced FGFR and VEGFR inhibitor with strong activity on primary and metastatic tumor growth in FGFR-dependent and angiogenic cancer models","display_name":"Abstract 4133: ODM-203, a novel, selective and balanced FGFR and VEGFR inhibitor with strong activity on primary and metastatic tumor growth in FGFR-dependent and angiogenic cancer models","publication_year":2015,"publication_date":"2015-08-01","ids":{"openalex":"https://openalex.org/W1419085830","doi":"https://doi.org/10.1158/1538-7445.am2015-4133","mag":"1419085830"},"language":"en","primary_location":{"id":"doi:10.1158/1538-7445.am2015-4133","doi":"https://doi.org/10.1158/1538-7445.am2015-4133","is_oa":false,"landing_page_url":"https://doi.org/10.1158/1538-7445.am2015-4133","pdf_url":null,"source":{"id":"https://openalex.org/S168522863","display_name":"Cancer Research","issn_l":"0008-5472","issn":["0008-5472","1538-7445"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer Research","raw_type":"journal-article"},"volume":null,"type":"conference-abstract","is_traditional":false,"indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5031503332","display_name":"Tim H. Holmstr\u00f6m","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210118237","display_name":"Orion Corporation (Finland)","ror":"https://ror.org/0296s4x19","country_code":"FI","type":"company","lineage":["https://openalex.org/I4210118237"]}],"countries":["FI"],"is_corresponding":false,"raw_author_name":"Tim Holmstr\u00f6m","raw_affiliation_strings":["1Orion Corporation Orion Pharma, Espoo, Finland;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Orion Corporation Orion Pharma, Espoo, Finland;","institution_ids":["https://openalex.org/I4210118237"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5110172886","display_name":"Anu Moilanen","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210118237","display_name":"Orion Corporation (Finland)","ror":"https://ror.org/0296s4x19","country_code":"FI","type":"company","lineage":["https://openalex.org/I4210118237"]}],"countries":["FI"],"is_corresponding":false,"raw_author_name":"Anu Moilanen","raw_affiliation_strings":["1Orion Corporation Orion Pharma, Espoo, Finland;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Orion Corporation Orion Pharma, Espoo, Finland;","institution_ids":["https://openalex.org/I4210118237"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5081474353","display_name":"Mari L. Bj\u00f6rkman","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210118237","display_name":"Orion Corporation (Finland)","ror":"https://ror.org/0296s4x19","country_code":"FI","type":"company","lineage":["https://openalex.org/I4210118237"]}],"countries":["FI"],"is_corresponding":false,"raw_author_name":"Mari Bj\u00f6rkman","raw_affiliation_strings":["1Orion Corporation Orion Pharma, Espoo, Finland;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Orion Corporation Orion Pharma, Espoo, Finland;","institution_ids":["https://openalex.org/I4210118237"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5021313660","display_name":"Tero Linnanen","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210118237","display_name":"Orion Corporation (Finland)","ror":"https://ror.org/0296s4x19","country_code":"FI","type":"company","lineage":["https://openalex.org/I4210118237"]}],"countries":["FI"],"is_corresponding":false,"raw_author_name":"Tero Linnanen","raw_affiliation_strings":["1Orion Corporation Orion Pharma, Espoo, Finland;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Orion Corporation Orion Pharma, Espoo, Finland;","institution_ids":["https://openalex.org/I4210118237"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5075892383","display_name":"Gerd Wohlfahrt","orcid":"https://orcid.org/0000-0003-0530-2000","observed_orcids":["https://orcid.org/0000-0003-0530-2000"]},"institutions":[{"id":"https://openalex.org/I4210118237","display_name":"Orion Corporation (Finland)","ror":"https://ror.org/0296s4x19","country_code":"FI","type":"company","lineage":["https://openalex.org/I4210118237"]}],"countries":["FI"],"is_corresponding":false,"raw_author_name":"Gerd Wohlfahrt","raw_affiliation_strings":["1Orion Corporation Orion Pharma, Espoo, Finland;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Orion Corporation Orion Pharma, Espoo, Finland;","institution_ids":["https://openalex.org/I4210118237"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5076904615","display_name":"Stefan Karlsson","orcid":"https://orcid.org/0000-0003-3421-7198","observed_orcids":["https://orcid.org/0000-0003-3421-7198"]},"institutions":[{"id":"https://openalex.org/I4210118237","display_name":"Orion Corporation (Finland)","ror":"https://ror.org/0296s4x19","country_code":"FI","type":"company","lineage":["https://openalex.org/I4210118237"]}],"countries":["FI"],"is_corresponding":false,"raw_author_name":"Stefan Karlsson","raw_affiliation_strings":["1Orion Corporation Orion Pharma, Espoo, Finland;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Orion Corporation Orion Pharma, Espoo, Finland;","institution_ids":["https://openalex.org/I4210118237"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5082795809","display_name":"Riikka Oksala","orcid":"https://orcid.org/0000-0001-6256-562X","observed_orcids":["https://orcid.org/0000-0001-6256-562X"]},"institutions":[{"id":"https://openalex.org/I4210118237","display_name":"Orion Corporation (Finland)","ror":"https://ror.org/0296s4x19","country_code":"FI","type":"company","lineage":["https://openalex.org/I4210118237"]}],"countries":["FI"],"is_corresponding":false,"raw_author_name":"Riikka Oksala","raw_affiliation_strings":["1Orion Corporation Orion Pharma, Espoo, Finland;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Orion Corporation Orion Pharma, Espoo, Finland;","institution_ids":["https://openalex.org/I4210118237"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5051890127","display_name":"Timo Korjamo","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210118237","display_name":"Orion Corporation (Finland)","ror":"https://ror.org/0296s4x19","country_code":"FI","type":"company","lineage":["https://openalex.org/I4210118237"]}],"countries":["FI"],"is_corresponding":false,"raw_author_name":"Timo Korjamo","raw_affiliation_strings":["1Orion Corporation Orion Pharma, Espoo, Finland;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Orion Corporation Orion Pharma, Espoo, Finland;","institution_ids":["https://openalex.org/I4210118237"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5039885523","display_name":"Susanta Samajdar","orcid":"https://orcid.org/0000-0002-3508-4801","observed_orcids":["https://orcid.org/0000-0002-3508-4801"]},"institutions":[{"id":"https://openalex.org/I4210152788","display_name":"Aurigene Discovery Technologies (India)","ror":"https://ror.org/05k1y3v43","country_code":"IN","type":"company","lineage":["https://openalex.org/I4210152788"]}],"countries":["IN"],"is_corresponding":false,"raw_author_name":"Susanta Samajdar","raw_affiliation_strings":["2Aurigene Discovery Technologies Limited, Bangalore, India"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"2Aurigene Discovery Technologies Limited, Bangalore, India","institution_ids":["https://openalex.org/I4210152788"]}]},{"author_position":"middle","author":{"id":null,"display_name":"Srinivasan Rajagopalan","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210152788","display_name":"Aurigene Discovery Technologies (India)","ror":"https://ror.org/05k1y3v43","country_code":"IN","type":"company","lineage":["https://openalex.org/I4210152788"]}],"countries":["IN"],"is_corresponding":false,"raw_author_name":"Srinivasan Rajagopalan","raw_affiliation_strings":["2Aurigene Discovery Technologies Limited, Bangalore, India"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"2Aurigene Discovery Technologies Limited, Bangalore, India","institution_ids":["https://openalex.org/I4210152788"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5024438197","display_name":"Shekar Chelur","orcid":"https://orcid.org/0000-0001-7017-4063","observed_orcids":["https://orcid.org/0000-0001-7017-4063"]},"institutions":[{"id":"https://openalex.org/I4210152788","display_name":"Aurigene Discovery Technologies (India)","ror":"https://ror.org/05k1y3v43","country_code":"IN","type":"company","lineage":["https://openalex.org/I4210152788"]}],"countries":["IN"],"is_corresponding":false,"raw_author_name":"Shekar Chelur","raw_affiliation_strings":["2Aurigene Discovery Technologies Limited, Bangalore, India"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"2Aurigene Discovery Technologies Limited, Bangalore, India","institution_ids":["https://openalex.org/I4210152788"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5055416709","display_name":"Kishore Narayan","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210152788","display_name":"Aurigene Discovery Technologies (India)","ror":"https://ror.org/05k1y3v43","country_code":"IN","type":"company","lineage":["https://openalex.org/I4210152788"]}],"countries":["IN"],"is_corresponding":false,"raw_author_name":"Kishore Narayan","raw_affiliation_strings":["2Aurigene Discovery Technologies Limited, Bangalore, India"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"2Aurigene Discovery Technologies Limited, Bangalore, India","institution_ids":["https://openalex.org/I4210152788"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5085141768","display_name":"Raghuveer K. Ramachandra","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210152788","display_name":"Aurigene Discovery Technologies (India)","ror":"https://ror.org/05k1y3v43","country_code":"IN","type":"company","lineage":["https://openalex.org/I4210152788"]}],"countries":["IN"],"is_corresponding":false,"raw_author_name":"Raghuveer Ramachandra","raw_affiliation_strings":["2Aurigene Discovery Technologies Limited, Bangalore, India"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"2Aurigene Discovery Technologies Limited, Bangalore, India","institution_ids":["https://openalex.org/I4210152788"]}]},{"author_position":"middle","author":{"id":null,"display_name":"Thomas Anthony","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210152788","display_name":"Aurigene Discovery Technologies (India)","ror":"https://ror.org/05k1y3v43","country_code":"IN","type":"company","lineage":["https://openalex.org/I4210152788"]}],"countries":["IN"],"is_corresponding":false,"raw_author_name":"Thomas Anthony","raw_affiliation_strings":["2Aurigene Discovery Technologies Limited, Bangalore, India"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"2Aurigene Discovery Technologies Limited, Bangalore, India","institution_ids":["https://openalex.org/I4210152788"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5055443000","display_name":"DS Samiulla","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210152788","display_name":"Aurigene Discovery Technologies (India)","ror":"https://ror.org/05k1y3v43","country_code":"IN","type":"company","lineage":["https://openalex.org/I4210152788"]}],"countries":["IN"],"is_corresponding":false,"raw_author_name":"Samiulla DS","raw_affiliation_strings":["2Aurigene Discovery Technologies Limited, Bangalore, India"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"2Aurigene Discovery Technologies Limited, Bangalore, India","institution_ids":["https://openalex.org/I4210152788"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5065784113","display_name":"Murali Ramachandra","orcid":"https://orcid.org/0000-0003-4039-1491","observed_orcids":["https://orcid.org/0000-0003-4039-1491"]},"institutions":[{"id":"https://openalex.org/I4210152788","display_name":"Aurigene Discovery Technologies (India)","ror":"https://ror.org/05k1y3v43","country_code":"IN","type":"company","lineage":["https://openalex.org/I4210152788"]}],"countries":["IN"],"is_corresponding":false,"raw_author_name":"Murali Ramachandra","raw_affiliation_strings":["2Aurigene Discovery Technologies Limited, Bangalore, India"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"2Aurigene Discovery Technologies Limited, Bangalore, India","institution_ids":["https://openalex.org/I4210152788"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5016359992","display_name":"Pekka J. Kallio","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210118237","display_name":"Orion Corporation (Finland)","ror":"https://ror.org/0296s4x19","country_code":"FI","type":"company","lineage":["https://openalex.org/I4210118237"]}],"countries":["FI"],"is_corresponding":false,"raw_author_name":"Pekka Kallio","raw_affiliation_strings":["1Orion Corporation Orion Pharma, Espoo, Finland;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Orion Corporation Orion Pharma, Espoo, Finland;","institution_ids":["https://openalex.org/I4210118237"]}]}],"institutions":[],"countries_distinct_count":2,"institutions_distinct_count":2,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"75","issue":"15_Supplement","first_page":"4133","last_page":"4133"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T12287","display_name":"Fibroblast Growth Factor Research","score":0.8109999895095825,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T12287","display_name":"Fibroblast Growth Factor Research","score":0.8109999895095825,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10422","display_name":"Angiogenesis and VEGF in Cancer","score":0.18850000202655792,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T13779","display_name":"Cancer Mechanisms and Therapy","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/1306","display_name":"Cancer Research"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/fgfr-inhibitors","display_name":"FGFR inhibitors","score":0.9190000295639038},{"id":"https://openalex.org/keywords/vegfr-tyrosine-kinase-inhibitors","display_name":"VEGFR inhibitors","score":0.9990000128746033},{"id":"https://openalex.org/keywords/tumor-angiogenesis","display_name":"tumor angiogenesis","score":0.8799999952316284},{"id":"https://openalex.org/keywords/metastatic-tumor-growth","display_name":"metastatic tumor growth","score":0.8429999947547913},{"id":"https://openalex.org/keywords/endothelial-cell-proliferation","display_name":"endothelial cell proliferation","score":0.7379999756813049},{"id":"https://openalex.org/keywords/xenograft-models","display_name":"xenograft models","score":0.7099999785423279},{"id":"https://openalex.org/keywords/solid-tumors","display_name":"solid tumors","score":0.7070000171661377},{"id":"https://openalex.org/keywords/kinase-inhibitor-selectivity","display_name":"kinase selectivity","score":0.4880000054836273},{"id":"https://openalex.org/keywords/gastric-cancer","display_name":"gastric cancer","score":0.6190000176429749},{"id":"https://openalex.org/keywords/lung-cancer","display_name":"lung cancer","score":0.8769999742507935},{"id":"https://openalex.org/keywords/breast-cancer","display_name":"breast cancer","score":1.0},{"id":"https://openalex.org/keywords/anti-angiogenic-therapy","display_name":"anti-angiogenic therapy","score":0.5989999771118164}],"concepts":[{"id":"https://openalex.org/C82867764","wikidata":"https://www.wikidata.org/wiki/Q24780051","display_name":"Fibroblast growth factor receptor","level":4,"score":0.847099781036377},{"id":"https://openalex.org/C2780394083","wikidata":"https://www.wikidata.org/wiki/Q539568","display_name":"Angiogenesis","level":2,"score":0.7236229181289673},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.6176504492759705},{"id":"https://openalex.org/C207001950","wikidata":"https://www.wikidata.org/wiki/Q141124","display_name":"In vivo","level":2,"score":0.5619887113571167},{"id":"https://openalex.org/C74373430","wikidata":"https://www.wikidata.org/wiki/Q24727126","display_name":"Fibroblast growth factor","level":3,"score":0.5096235275268555},{"id":"https://openalex.org/C184235292","wikidata":"https://www.wikidata.org/wiki/Q421851","display_name":"Kinase","level":2,"score":0.5014395713806152},{"id":"https://openalex.org/C2777025900","wikidata":"https://www.wikidata.org/wiki/Q29725","display_name":"Vascular endothelial growth factor","level":3,"score":0.454974889755249},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.45313918590545654},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.42943474650382996},{"id":"https://openalex.org/C49418065","wikidata":"https://www.wikidata.org/wiki/Q14914258","display_name":"Fibroblast growth factor receptor 1","level":4,"score":0.4284099340438843},{"id":"https://openalex.org/C2779013556","wikidata":"https://www.wikidata.org/wiki/Q181876","display_name":"Metastasis","level":3,"score":0.41816478967666626},{"id":"https://openalex.org/C14858245","wikidata":"https://www.wikidata.org/wiki/Q18028241","display_name":"Kinase insert domain receptor","level":5,"score":0.41737955808639526},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.38385871052742004},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.371785044670105},{"id":"https://openalex.org/C134018914","wikidata":"https://www.wikidata.org/wiki/Q162606","display_name":"Endocrinology","level":1,"score":0.3569740653038025},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.3345981538295746},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.3237186670303345},{"id":"https://openalex.org/C146285616","wikidata":"https://www.wikidata.org/wiki/Q7916455","display_name":"Vascular endothelial growth factor A","level":4,"score":0.26600950956344604},{"id":"https://openalex.org/C95444343","wikidata":"https://www.wikidata.org/wiki/Q7141","display_name":"Cell biology","level":1,"score":0.1741621196269989},{"id":"https://openalex.org/C167734588","wikidata":"https://www.wikidata.org/wiki/Q4356503","display_name":"VEGF receptors","level":2,"score":0.0},{"id":"https://openalex.org/C150903083","wikidata":"https://www.wikidata.org/wiki/Q7108","display_name":"Biotechnology","level":1,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1158/1538-7445.am2015-4133","doi":"https://doi.org/10.1158/1538-7445.am2015-4133","is_oa":false,"landing_page_url":"https://doi.org/10.1158/1538-7445.am2015-4133","pdf_url":null,"source":{"id":"https://openalex.org/S168522863","display_name":"Cancer Research","issn_l":"0008-5472","issn":["0008-5472","1538-7445"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer Research","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"score":0.9391000270843506,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2897182820","https://openalex.org/W1976715358","https://openalex.org/W2314425995","https://openalex.org/W4411576066","https://openalex.org/W2142702787","https://openalex.org/W2097964779","https://openalex.org/W2473526019","https://openalex.org/W7099126689","https://openalex.org/W2270120907","https://openalex.org/W1534728132"],"abstract_inverted_index":{"Abstract":[0],"Genomic":[1],"alterations":[2,34],"in":[3,21,94,97,112,149,163,168,184,191,225,227,262,276,338],"fibroblast":[4],"growth":[5,14,183,261,337],"factor":[6,15],"receptors":[7,16,92],"(FGFR)":[8],"and":[9,30,32,39,46,78,84,96,108,125,167,194,229,246,258,264,323,326,334,340],"upregulation":[10],"of":[11,53,69,81,189,204,206,210,347,352],"vascular":[12],"endothelial":[13,135],"(VEGFR)":[17],"are":[18],"often":[19],"found":[20],"the":[22,82,106,113,201,348,353],"same":[23],"cancer":[24,342],"types":[25],"such":[26],"as":[27,62,145],"gastric,":[28],"lung":[29],"breast":[31],"these":[33],"correlate":[35],"with":[36,128,142,172,215,240,252,253,272,278,329],"patient":[37],"survival":[38],"disease":[40],"progression.":[41],"In":[42,99,120,156,177],"addition,":[43],"both":[44,91,93,105,244],"FGFR":[45,54,83,107,124,193,217,245,325],"VEGFR":[47,85,109,126,195,219,247,327],"signaling":[48,55,127],"promote":[49],"tumor":[50,182,197,260,266,336],"angiogenesis.":[51],"Activation":[52],"has":[56,236],"also":[57,132],"been":[58],"described":[59],"to":[60,71,90],"function":[61],"a":[63,76,192,237,269,320],"compensatory":[64],"angiogenic":[65,169,185,265,341],"signal":[66],"following":[67],"development":[68],"resistance":[70],"VEGF":[72],"inhibition.":[73],"ODM-203":[74,103,122,158,179,211,235,273],"is":[75,274],"novel":[77],"selective":[79,202,322],"inhibitor":[80,328],"families":[86,249],"exhibiting":[87],"equal":[88,241],"potency":[89,144,242],"vitro":[95],"vivo.":[98],"recombinant":[100],"kinase":[101,248],"assays,":[102],"inhibits":[104,133,147,180],"family":[110],"kinases":[111],"low":[114],"nanomolar":[115],"range":[116],"(IC50":[117,139,153],"6-35":[118],"nM).":[119,155],"cells,":[121],"suppresses":[123],"similar":[129,143,173],"potency.":[130],"It":[131],"VEGF-induced":[134],"cell":[136,151],"(HUVEC)":[137],"proliferation":[138,148],"33":[140],"nM)":[141],"it":[146],"FGFR-dependent":[150,164,263,339],"lines":[152],"50-150":[154],"vivo,":[157],"shows":[159],"strong":[160,254,330],"anti-tumor":[161],"activity":[162,190,255,331],"xenograft":[165,170,186],"models":[166,171,198],"well":[174,213],"tolerated":[175,214],"doses.":[176],"addition":[178],"metastatic":[181,259,335],"models.":[187,267,343],"Lack":[188],"independent":[196],"further":[199],"supports":[200],"mode":[203],"action":[205],"ODM-203.":[207],"Oral":[208],"administration":[209],"was":[212],"only":[216],"or":[218],"inhibition":[220],"related":[221],"physiological":[222],"events":[223],"observed":[224],"vivo":[226],"rat":[228],"dog.":[230],"Based":[231],"on":[232,256,332],"our":[233],"findings,":[234],"unique":[238],"profile":[239],"for":[243,356],"which":[250],"correlates":[251],"primary":[257,333],"Therefore,":[268],"clinical":[270],"trial":[271],"ongoing":[275],"patients":[277],"solid":[279],"tumors":[280],"(NCT":[281],"02264418).":[282],"Citation":[283],"Format:":[284],"Tim":[285],"Holmstr\u00f6m,":[286],"Anu":[287],"Moilanen,":[288],"Mari":[289],"Bj\u00f6rkman,":[290],"Tero":[291],"Linnanen,":[292],"Gerd":[293],"Wohlfahrt,":[294],"Stefan":[295],"Karlsson,":[296],"Riikka":[297],"Oksala,":[298],"Timo":[299],"Korjamo,":[300],"Susanta":[301],"Samajdar,":[302],"Srinivasan":[303],"Rajagopalan,":[304],"Shekar":[305],"Chelur,":[306],"Kishore":[307],"Narayan,":[308],"Raghuveer":[309],"Ramachandra,":[310,316],"Thomas":[311],"Anthony,":[312],"Samiulla":[313],"DS,":[314],"Murali":[315],"Pekka":[317],"Kallio.":[318],"ODM-203,":[319],"novel,":[321],"balanced":[324],"[abstract].":[344],"In:":[345],"Proceedings":[346],"106th":[349],"Annual":[350],"Meeting":[351],"American":[354],"Association":[355],"Cancer":[357,367],"Research;":[358],"2015":[359],"Apr":[360],"18-22;":[361],"Philadelphia,":[362],"PA.":[363],"Philadelphia":[364],"(PA):":[365],"AACR;":[366],"Res":[368],"2015;75(15":[369],"Suppl):Abstract":[370],"nr":[371],"4133.":[372],"doi:10.1158/1538-7445.AM2015-4133":[373]},"counts_by_year":[],"updated_date":"2026-09-29T14:09:16.559479","created_date":"2016-06-24T00:00:00"}